1. Home
  2. TMDE vs IGC Comparison

TMDE vs IGC Comparison

Compare TMDE & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$2.09

Market Cap

21.7M

Sector

Energy

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.27

Market Cap

25.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
IGC
Founded
2016
2005
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
25.0M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TMDE
IGC
Price
$2.09
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
2.5M
231.2K
Earning Date
05-13-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.09
EPS
N/A
N/A
Revenue
N/A
$1,271,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$15.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.24
52 Week High
$4.77
$0.50

Technical Indicators

Market Signals
Indicator
TMDE
IGC
Relative Strength Index (RSI) 57.94 47.79
Support Level $0.64 $0.25
Resistance Level $2.75 $0.31
Average True Range (ATR) 0.25 0.02
MACD 0.02 -0.00
Stochastic Oscillator 73.38 44.00

Price Performance

Historical Comparison
TMDE
IGC

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: